| Strain-promoted azide–alkyne cycloaddition-based PSMA-targeting ligands for multimodal intraoperative tumor detection of prostate cancer YHW Derks, M Rijpkema, HIV Amatdjais-Groenen, CC Loeff, ... Bioconjugate chemistry 33 (1), 194-205, 2021 | 12 | 2021 |
| Towards the magic radioactive bullet: improving targeted radionuclide therapy by reducing the renal retention of radioligands KE de Roode, L Joosten, M Behe Pharmaceuticals 17 (2), 256, 2024 | 10 | 2024 |
| Click-to-Release: Cleavable Radioimmunoimaging with [89Zr] Zr-DFO-Trans-Cyclooctene-Trastuzumab Increases Tumor-to-Blood Ratio M Vlastara, R Rossin, FJM Hoeben, KE de Roode, M Boswinkel, ... Theranostics 13 (12), 4004, 2023 | 9 | 2023 |
| Tumor‐On‐A‐Chip Models for Predicting In Vivo Nanoparticle Behavior KE de Roode, K Hashemi, WPR Verdurmen, R Brock Small, 2402311, 2024 | 5 | 2024 |
| Click-cleavable 111In/177Lu-labeled DOTA-TCO-trastuzumab for imaging and therapy of breast cancer K de Roode, R Versteegen, L Kleijn, R Rossin, M Robillard Nuclear Medicine and Biology 114, S16, 2022 | 1 | 2022 |
| Masked il12 protein MHMGM DEN, MS Robillard, R Rossin, LHJ KLEIJN, KE DE ROODE, ... | | 2023 |
